Key points
- Setting: In late-stage drug discovery, molecular modification starts from a lead compound, and chemists must decide which of thousands of possible analogues to synthesize first. Predicting reaction sites (where bonds break and form) is the key.
- Method: Minot et al. propose in Nature Computational Science a closed loop of active learning and geometric deep learning: the model actively picks the experiments most worth running, and the results feed back to keep improving it, while a symmetry-aware network extracts more information from each labeled experiment.
- Validation: Under a scaffold split, which is closer to real discovery settings, graph neural networks clearly outperform XGBoost. The study also released a public dataset, creating a validation template for data-efficient chemistry.
Analysis
The highlight is the "closed loop" rather than a single model: active learning turns experiment selection itself into an optimization problem, while geometric deep learning makes small data go a long way. The authors are also candid: EquiformerV2 loses accuracy on the most complex substrates, and the field still needs larger and more diverse public reaction data. The future question is no longer "can this molecule be made?" but "which of thousands of analogues should be made first?"
Source: AI Chemists Learn Where to Break Molecules: Active Learning Steers Drug Discovery Reactions. This text is a summary for reference only.
